Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Arbuthnot

Showing results (41-50 of 101) with videos related to

Pageof 11
Sort By:
International Journal of Molecular Sciences|August 13, 2015
Progress and Prospects of Anti-HBV Gene Therapy DevelopmentMohube B Maepa, Ilke Roelofse, Abdullah Ely, et al.
Molecular Therapy. Nucleic Acids|June 19, 2017
Sustained Inhibition of HBV Replication In Vivo after Systemic Injection of AAVs Encoding Artificial Antiviral Primary MicroRNAsMohube Betty Maepa, Abdullah Ely, Wayne Grayson, et al.
Current Topics in Medicinal Chemistry|October 29, 2009
RNA interference-based gene expression strategies aimed at sustained therapeutic inhibition of HIVSamantha Barichievy, Sheena Saayman, Patrick Arbuthnot, et al.
Future Microbiology|November 9, 2013
Recent advances in developing nucleic acid-based HBV therapyMusa Marimani, Justin Hean, Kristie Bloom, et al.
Frontiers in Immunology|February 14, 2022
Diversity of Dysregulated Long Non-Coding RNAs in HBV-Related Hepatocellular CarcinomaNazia Samudh, Creanne Shrilall, Patrick Arbuthnot, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 26, 2013
Inactivation of hepatitis B virus replication in cultured cells and in vivo with engineered transcription activator-like effector nucleasesKristie Bloom, Abdullah Ely, Claudio Mussolino, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 24, 2008
Expressed anti-HBV primary microRNA shuttles inhibit viral replication efficiently in vitro and in vivoAbdullah Ely, Tanusha Naidoo, Steven Mufamadi, et al.
Virus Research|January 15, 2017
Advances with using CRISPR/Cas-mediated gene editing to treat infections with hepatitis B virus and hepatitis C virusBuhle Moyo, Kristie Bloom, Tristan Scott, et al.
Biochemical and Biophysical Research Communications|September 4, 2016
Improved antiviral efficacy using TALEN-mediated homology directed recombination to introduce artificial primary miRNAs into DNA of hepatitis B virusTimothy Dreyer, Samantha Nicholson, Abdullah Ely, et al.
Virology Journal|December 14, 2021
Advances in designing Adeno-associated viral vectors for development of anti-HBV gene therapeuticsNjabulo Mnyandu, Shonisani Wendy Limani, Patrick Arbuthnot, et al.
Pageof 11

Showing results (41-50 of 101) with videos related to

Sort By:
Pageof 11
International Journal of Molecular Sciences|August 13, 2015
Progress and Prospects of Anti-HBV Gene Therapy DevelopmentMohube B Maepa, Ilke Roelofse, Abdullah Ely, et al.
Molecular Therapy. Nucleic Acids|June 19, 2017
Sustained Inhibition of HBV Replication In Vivo after Systemic Injection of AAVs Encoding Artificial Antiviral Primary MicroRNAsMohube Betty Maepa, Abdullah Ely, Wayne Grayson, et al.
Current Topics in Medicinal Chemistry|October 29, 2009
RNA interference-based gene expression strategies aimed at sustained therapeutic inhibition of HIVSamantha Barichievy, Sheena Saayman, Patrick Arbuthnot, et al.
Future Microbiology|November 9, 2013
Recent advances in developing nucleic acid-based HBV therapyMusa Marimani, Justin Hean, Kristie Bloom, et al.
Frontiers in Immunology|February 14, 2022
Diversity of Dysregulated Long Non-Coding RNAs in HBV-Related Hepatocellular CarcinomaNazia Samudh, Creanne Shrilall, Patrick Arbuthnot, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 26, 2013
Inactivation of hepatitis B virus replication in cultured cells and in vivo with engineered transcription activator-like effector nucleasesKristie Bloom, Abdullah Ely, Claudio Mussolino, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 24, 2008
Expressed anti-HBV primary microRNA shuttles inhibit viral replication efficiently in vitro and in vivoAbdullah Ely, Tanusha Naidoo, Steven Mufamadi, et al.
Virus Research|January 15, 2017
Advances with using CRISPR/Cas-mediated gene editing to treat infections with hepatitis B virus and hepatitis C virusBuhle Moyo, Kristie Bloom, Tristan Scott, et al.
Biochemical and Biophysical Research Communications|September 4, 2016
Improved antiviral efficacy using TALEN-mediated homology directed recombination to introduce artificial primary miRNAs into DNA of hepatitis B virusTimothy Dreyer, Samantha Nicholson, Abdullah Ely, et al.
Virology Journal|December 14, 2021
Advances in designing Adeno-associated viral vectors for development of anti-HBV gene therapeuticsNjabulo Mnyandu, Shonisani Wendy Limani, Patrick Arbuthnot, et al.
Pageof 11